2024

1. Corrigendum to “European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO” [Eur J Surg Oncol 50 (1) (January 2024) 107292] (European Journal of Surgical Oncology (2024) 50(1), (S0748798323009307), (10.1016/j.ejso.2023.107292))

   European Journal of Surgical Oncology

2. EUSOMA quality indicators for non-metastatic breast cancer: An update

   European Journal of Cancer, Vol. 198

3. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO

   European Journal of Surgical Oncology, Vol. 50, Núm. 1

4. Post- versus intra-operative implant for breast cancer interstitial brachytherapy: How to choose?

   Journal of Contemporary Brachytherapy, Vol. 16, Núm. 1, pp. 72-83